The vaccines have arrived, and that gives us hope of reining in the spread of coronavirus. COVID-19 consumed much of last year, killing people and battering economies. If 2021 has to be an improvement, a sizeable part of the world’s population should be vaccinated.
We have at least five proven vaccines. And all of them have been found to be effective in priming our immune system to fight the coronavirus. They help create antibodies, which are the ammunition for our body to eliminate pathogens.
There are antibody drugs too. They are given to vulnerable patients in the early days of infection. It has prevented them from being hospitalised and enabled them to return to active life soon. But these medicines are yet to catch on, although US President Donald Trump was one of the recipients. Several Trump administration officials were also treated with monoclonal antibody medicines.
E-Mail
Noncognitive skills and cognitive abilities are both important contributors to educational attainment the number of years of formal schooling that a person completes and lead to success across the life course, according to a new study from an international team led by researchers at Columbia University Mailman School of Public Health, the University of Texas at Austin, and Vrije Universiteit Amsterdam. The research provides evidence for the idea that inheriting genes that affect things other than cognitive ability are important for understanding differences in people s life outcomes. Until now there had been questions about what these noncognitive skills are and how much they really matter for life outcomes. The new findings are published in the journal
Statewide coronavirus update: Indiana reports 7,344 cases, 81 deaths IndyStar, Indianapolis Star
Replay Video UP NEXT
Indiana on Thursday reported 7,344 new cases of coronavirus and an additional 81 deaths, bringing the state s totals since the start of the pandemic to 546,499 cases and 8,452 deaths.
Wednesday saw the highest number of new cases reported for any one day since Dec. 11. All but three counties in the state have a seven-day positivity rate of at least 10%.
More than 2.7 million Hoosiers have now had at least one test for coronavirus in the past 10 months.
How many people in Indiana hospitals with COVID-19: 2,812.
State positivity rates (seven-day rate as of Dec. 31): For all tests performed, 16.4%. For unique individuals, 27.8%.
Medigen to begin phase 2 vaccine candidate trials
By Kao Shih-ching / Staff reporter
Medigen Vaccine Biologics Corp (高端疫苗) on Wednesday said it plans to begin phase 2 clinical trials next week for its COVID-19 vaccine candidate and expects to apply by the end of June for emergency use authorization for the drug.
The company has started recruiting participants after last week obtaining Food and Drug Administration (FDA) permission to launch the phase 2 trials.
The company plans to recruit 3,700 participants, the most ever in such trials in Taiwan, as it aims to effectively examine the efficacy of its vaccine over the next three months, it said.
Blog
Blog
Blog
Blog
4 Jan, 2021 Author Donna Young
The U.S. Food and Drug Administration s Center for Drug Evaluation and Research approved 53 first-of-their-kind medicines in 2020, demonstrating the pandemic did not slow the agency s efforts in clearing novel drugs for the U.S. market.
The FDA tied its 1996 record for approving new molecular entities, or NMEs an all-time high that was shattered in 2018 when regulators in the Center for Drug Evaluation and Research, or CDER, cleared 59 novel therapies.
CDER approved 48 NMEs in 2019.
US FDA Commissioner Stephen Hahn
Source: U.S. Food and Drug Administration
The 53 NME approvals in 2020 will give FDA Commissioner Stephen Hahn a high note on which to depart the agency after a year of defending his actions in the pandemic against a number of critics, including President Donald Trump, who made unsubstantiated claims the regulatory chief and the scientists he oversees moved too sl